Literature DB >> 19886322

Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives.

Mohammad Qamar1, Heena Sheth, Filitsa H Bender, Beth Piraino.   

Abstract

The Kidney Disease Outcomes Quality Initiative guidelines for peritoneal dialysis (PD) emphasize the need for quality improvement interventions to improve outcomes in PD. Here, we report 17 years experience of initiatives focused on lowering peritonitis rates in a single PD program. This institutional review board-approved retrospective analysis used a PD registry containing prospectively collected data on patient demographics, initial Charlson comorbidity index (CCI), peritonitis, and clinical outcomes, including reasons for transfer to hemodialysis. Periods were analyzed based on quality initiatives: 1990 - 1991, baseline; 1992 - 1995, randomized controlled trial of exit-site infection prophylaxis comparing mupirocin cream applied daily to the exit site with oral cyclical (every 12 weeks) rifampin; 1996 - 1999, compact assist device introduced for spiking on the cycler; 2000 - 2004, randomized controlled trial comparing daily gentamicin cream with mupirocin as exit-site prophylaxis; and 2005 - 2007, gentamicin prophylaxis implemented as routine care (2005) and retraining of all patients (2006). Infection rates and technique failure rates in each period were compared with baseline rates using incident rate ratio analysis. A total of 382 PD patients were evaluated [median age: 50 years (range: 18 - 90 years); 54% women; 19% African American; 36% with diabetes; median CCI: 5 (range: 2 - 14)]. The peritonitis rate declined from 0.5 episodes per year at risk in 1990 - 1991 to 0.25 episodes per year at risk in 2005 - 2007 (p < 0.004). The exit-site infection rate declined from 0.72 episodes per year at risk to 0.1 episodes per year at risk over the same period (p < 0.0001). The percentage of patients transferring to hemodialysis did not change significantly over time (overall 14%, varying from 12% to 17% annually), nor did the mortality rate, which varied from 115 per 1000 years to 171 per 1000 years. We conclude that quality improvement initiatives can reduce infection rates in PD patients.

Entities:  

Mesh:

Year:  2009        PMID: 19886322

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  7 in total

Review 1.  Peritoneal dialysis associated infections: An update on diagnosis and management.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-08-06

Review 2.  Peritoneal dialysis-related infections recommendations: 2016 update. What is new?

Authors:  Vassilios Liakopoulos; Olga Nikitidou; Theofanis Kalathas; Stefanos Roumeliotis; Marios Salmas; Theodoros Eleftheriadis
Journal:  Int Urol Nephrol       Date:  2017-06-01       Impact factor: 2.370

Review 3.  Continuous Quality Improvement Initiatives to Sustainably Reduce Peritoneal Dialysis-Related Infections in Australia and New Zealand.

Authors:  Melissa Nataatmadja; Yeoungjee Cho; David W Johnson
Journal:  Perit Dial Int       Date:  2016-09-10       Impact factor: 1.756

Review 4.  [Peritoneal dialysis from the beginnings up to today: which developments of the last decades were important?].

Authors:  Andreas Vychytil
Journal:  Wien Med Wochenschr       Date:  2013-04-17

5.  Predictors of peritonitis, hospital days, and technique survival for peritoneal dialysis patients in a managed care setting.

Authors:  Victoria A Kumar; Margo A Sidell; Wan-Ting Yang; Jason P Jones
Journal:  Perit Dial Int       Date:  2013-10-01       Impact factor: 1.756

6.  Optimizing Peritoneal Dialysis-Associated Peritonitis Prevention in the United States: From Standardized Peritoneal Dialysis-Associated Peritonitis Reporting and Beyond.

Authors:  Jeffrey Perl; Douglas S Fuller; Neil Boudville; Alan S Kliger; Douglas E Schaubel; Isaac Teitelbaum; Bradley A Warady; Alicia M Neu; Priti R Patel; Beth Piraino; Martin Schreiber; Ronald L Pisoni
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-06       Impact factor: 8.237

Review 7.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.